| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1991;52:1222-1229
© 1991 The Society of Thoracic Surgeons
Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York USA
* Address reprint requests to Dr Burt, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021 USA.
The development of a malignant esophagorespiratory fistula is a devastating complication. Data comparing various treatment options in a large group of patients are sparse. To assess the results of therapy, we reviewed our experience in 207 patients with malignant esophagorespiratory fistula. Records of 207 patients admitted to our institution with malignant esophagorespiratory fistula from 1926 to 1988 were reviewed and results of management analyzed. Age ranged from 21 to 90 years (median, 59 years); the male/female ratio was 3:1. Primary tumor site was esophagus in 161 (77%), lung in 33 (16%), trachea in 5 (2%), metastatic nodes in 4 (2%), larynx in 3 (1%), and thyroid in 1. Symptoms and signs of malignant esophagorespiratory fistula included cough in 116 (56%), aspiration in 77 (37%), fever in 52 (25%), dysphagia in 39 (19%), pneumonia in 11 (5%), hemoptysis in 10 (5%), and chest pain in 10 (5%). Respiratory location of fistula included trachea in 110 (53%), left main bronchus in 46 (22%), right bronchus in 33 (16%), lung parenchyma in 13 (6%), and multiple sites in 5 (2%). The percentage of patients alive at 3, 6, and 12 months by treatment modality was 13%, 4%, and 1% for supportive care (n = 104); 17%, 3%, and 0% for esophageal exclusion (n = 29); 21%, 14%, and 0% for esophageal intubation (n = 14); 30%, 15%, and 5% for radiation therapy (n = 20); and 46%, 20%, and 7% for esophageal bypass, respectively. Patients treated with radiation therapy and esophageal bypass had a significantly prolonged survival compared with patients treated with the other modalities. Age, sex, site of primary tumor, or site of fistula did not affect survival. In conclusion, the diagnosis of malignant esophagorespiratory fistula carries a grave prognosis. All therapy is aimed at palliation of respiratory tract contamination. Radiation therapy and esophageal bypass appear to offer survival advantage over supportive care or other modalities.
This article has been cited by other articles:
|
|
 |
|
  D. R. Spigel, J. D. Hainsworth, D. A. Yardley, E. Raefsky, J. Patton, N. Peacock, C. Farley, H. A. Burris III, and F. A. Greco Tracheoesophageal Fistula Formation in Patients With Lung Cancer Treated With Chemoradiation and Bevacizumab J. Clin. Oncol., January 1, 2010; 28(1): 43 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Alazemi, S. Chatterji, A. Ernst, D. Berkowitz, G. Michaud, and A. Majid Mediastinal Migration of Self-Expanding Bronchial Stents in the Management of Malignant Bronchoesophageal Fistula Chest, May 1, 2009; 135(5): 1353 - 1355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. KASUYA, K. OGAWA, H. SHIMOJI, W. TAMAKI, H. KARIMATA, T. TOITA, Y. KAKINOHANA, T. ARIGA, T. NISHIMAKI, and S. MURAYAMA Development of Gastro-lymphatic Fistula During Chemoradiotherapy for Advanced Esophageal Cancer: A Case Report Anticancer Res, February 1, 2009; 29(2): 525 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Balazs, P. K. Kupcsulik, and Z. Galambos Esophagorespiratory fistulas of tumorous origin. Non-operative management of 264 cases in a 20-year period Eur J Cardiothorac Surg, November 1, 2008; 34(5): 1103 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Shin, H.-Y. Song, G.-Y. Ko, J.-O. Lim, H.-K. Yoon, and K.-B. Sung Esophagorespiratory Fistula: Long-term Results of Palliative Treatment with Covered Expandable Metallic Stents in 61 Patients Radiology, July 1, 2004; 232(1): 252 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. Whooley, S. Law, S. C. Murthy, A. Alexandrou, K.-M. Chu, and J. Wong The Kirschner Operation in Unresectable Esophageal Cancer: Current Application Arch Surg, November 1, 2002; 137(11): 1228 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Franquet, J. J. Erasmus, A. Gimenez, S. Rossi, and R. Prats The Retrotracheal Space: Normal Anatomic and Pathologic Appearances RadioGraphics, October 1, 2002; 22(90001): S231 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A case of cough and dysphagia Postgrad. Med. J., February 1, 2002; 78(916): 111 - 111. [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Alexander, G. D. Trachiotis, T. O. Lipman, and R. G. Wadleigh Evolving management and outcome of esophageal cancer with airway involvement Ann. Thorac. Surg., May 1, 2001; 71(5): 1640 - 1644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Kassis, C. P. Belani, P. F. Ferson, R. J. Keenan, and J. D. Luketich Hodgkin's disease presenting with a bronchoesophageal fistula Ann. Thorac. Surg., October 1, 1998; 66(4): 1409 - 1410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Jougon and L. Couraud Esophageal patching for an unsuturable tracheoesophageal fistula Eur J Cardiothorac Surg, October 1, 1998; 14(4): 431 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Low and R. A. Kozarek Comparison of Conventional and Wire Mesh Expandable Prostheses and Surgical Bypass in Patients With Malignant Esophagorespiratory Fistulas Ann. Thorac. Surg., April 1, 1998; 65(4): 919 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Meunier, C. Stasik, J.-L. Raoul, Y. Spiliopoulos, M. Lakehal, J.-P. Campion, and B. Launois Gastric bypass for malignant esophagotracheal fistula: A series of 21 cases Eur J Cardiothorac Surg, February 1, 1998; 13(2): 184 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Trachiotis and W. R. Hix Repair of Tracheogastric Fistula After Cervical Exenteration Ann. Thorac. Surg., February 1, 1996; 61(2): 719 - 721. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
